Anne Covey joined the staff of Memorial Sloan Kettering in 2000 after completing a residency and fellowship in interventional radiology at Yale-New Haven Hospital. Her primary clinical focus is on diseases of the liver and bile ducts. This includes a variety of procedures such as arterial and portal vein embolization, biliary drainage, and thermal ablation of primary and metastatic liver tumors. At Memorial Sloan Kettering, she was the chair of the Radiology Research Committee, and currently she is a member of the Research Council, a scientific reviewed committee that reviews protocols for science, programmatic fit, resource allocation, and priority. On a national level, she is a writing member of the hepatobiliary panel of the National Comprehensive Cancer Network. In 2017, she became a Trustee of the American Board of Radiology and the Track Chair for the Interventional Oncology Series at the Radiological Society of North America.
Michael D’Angelica earned his M.D. at Tufts University School of Medicine in 1993, followed by a residency at the University of Connecticut Integrated General Surgery in 2000. He carried out a Research Fellowship at Memorial Sloan-Kettering Cancer Center from 1995 to 1997, serving as a Chief Administrative Fellow in 1996-1997. Dr. D’Angelica completed his Clinical Fellowship at Sloan-Kettering from 2000 to 2002. Currently, Dr. D’Angelica is an Assistant Attending in the Department of Surgery, Hepatopancreatobiliary Service at Memorial SloanKettering Cancer Center. He is a board-certified surgical oncologist with expertise in treating cancer of the liver, bile ducts, gall bladder, and pancreas. Dr. D’Angelica has a strong clinical interest in combining surgery, systemic chemotherapy, and hepatic arterial infusional chemotherapy (chemotherapy delivered directly to the liver through an implanted device) to treat tumors that have spread extensively throughout the liver. He has been very involved in research on the treatment of gallbladder, pancreas, and bile duct cancer. Members of his research group are studying tissues from surgical specimens to identify genetic changes in tumors to improve treatment outcomes and enable us to develop new treatments.
Hooman Yarmohammadi received his MD degree from the Shiraz University of Medical Sciences in Shiraz, Iran, and attended a general surgery residency at the Shiraz University of Medical Sciences. He completed a year of general surgery at the University of Pennsylvania Health System and completed a diagnostic radiology residency at University Hospitals, Case Medical Center, Cleveland, Ohio. He joined the division of interventional radiology and image-guided therapies at Memorial Sloan-Kettering Cancer Center (MSKCC) in 2013 after finishing an interventional radiology fellowship at Johns Hopkins Medical Institution. MSKCC advances in interventional oncology are among his highest priorities. His main focus is on the management and treatment of primary liver cancers, particularly HCC, and finding new methods for the treatment of pancreatic cancer.
